In vivo exploration of retinal nerve fiber layer morphology in Parkinson’s disease patients
Thinning of the retinal nerve fiber layer (RNFL) is a recently discovered feature of Parkinson’s disease (PD). Its exact pathological mechanism is yet unknown. We aimed to determine whether morphological changes of the RNFL are limited to RNFL thinning or also comprise an altered internal structure of this layer. Therefore, we investigated RNFL thickness and applied the RNFL attenuation coefficient (RNFL-AC), a novel method derived from optical coherence tomography, in PD patients and healthy controls (HCs). In this pilot study, we included 20 PD patients and 20 HCs matched for age, sex, and ethnicity. An ophthalmologist investigated all participants thoroughly, and we acquired retinal images from both eyes of each participant with a Spectralis optical coherence tomography system. We obtained both the RNFL-AC and RNFL thickness from peripapillary RNFL scans for the entire RNFL, as well as for each quadrant separately. We found no significant differences in the average RNFL-AC or the RNFL-AC of the separate retinal quadrants between PD patients and the HC group. However, compared to the HC group, PD patients had a significantly thinner RNFL in the temporal retinal quadrant. RNFL thinning was found in the temporal quadrant in PD patients without a corresponding change in the RNFL-AC. These findings suggest a reduction in the number of RNFL axons (atrophy) without other major changes in the structural integrity of the remaining RNFL.
KeywordsParkinson’s disease Optical coherence tomography Retinal nerve fiber layer Attenuation coefficient
This study would not have been possible without the financial support of the ‘Stichting ParkinsonFonds’. We would also like to thank Ms. Lisette van Hulst (teacher of Academic English) for her revision of the English language. In addition, we would like to thank all the participants who made this study possible.
This study was (partially) funded by the ‘Stichting ParkinsonFonds’.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N (2014) Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects. Neurosci Lett 571:34–38. https://doi.org/10.1016/j.neulet.2014.04.027 CrossRefPubMedPubMedCentralGoogle Scholar
- Fahn S, Marsden C, Calne D, Goldstein M (1987) Recent developments in Parkinsons disease, 2nd edn. Macmillan Healthcare Information, Florham Park, pp 153–163Google Scholar
- Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470–478472. https://doi.org/10.1016/j.ajo.2013.09.028 CrossRefPubMedGoogle Scholar
- La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C, Capellari S, Bonazza S, Giannoccaro MP, Calandra-Buonaura G, Liguori R, Cortelli P, Martinelli P, Baruzzi A, Carelli V (2013) Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 20(1):198–201. https://doi.org/10.1111/j.1468-1331.2012.03701.x CrossRefPubMedGoogle Scholar
- Stemplewitz B, Keseru M, Bittersohl D, Buhmann C, Skevas C, Richard G, Hassenstein A (2015) Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson’s disease. Acta Ophthalmol. https://doi.org/10.1111/aos.12764 CrossRefPubMedGoogle Scholar